Mount Sinai Health System is first in Northeast to use blood tests as an early detection tool for Alzheimer’s disease and related dementias in patients

Written by Stellate Comms
Stellate Comms

Stellate is a full-service, strategic communications firm. We sit at the intersection of science and everything it touches: health, technology, art, culture, community, and the greater human good. We work with the visionaries, innovators, scientists, and funders who are improving human health, protecting our planet, and moving society forward.

https://stellatecomms.com
Previous

CADASIL unveiled: The hidden link to strokes and migraines
Next

Shaping tomorrow’s medicine: How you can help prevent Alzheimer’s disease